Detalhe da pesquisa
1.
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.
N Engl J Med
; 389(1): 22-32, 2023 Jul 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37345876
2.
Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies.
J Hepatol
; 2024 Feb 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38340811
3.
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta.
J Hepatol
; 79(3): 657-665, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37120031
4.
Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation.
Gastroenterology
; 162(4): 1160-1170.e1, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34995536
5.
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment.
Clin Infect Dis
; 75(3): 453-459, 2022 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34864948
6.
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients.
J Viral Hepat
; 29(9): 807-816, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35657138
7.
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase.
Hepatology
; 73(5): 1652-1670, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32780526
8.
Sofosbuvir-velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in Japan.
Hepatol Res
; 52(10): 833-840, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35802063
9.
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.
J Hepatol
; 73(6): 1368-1378, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32707225
10.
Discovery of Half-life of Circulating Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B Infection Using Heavy Water Labeling.
Clin Infect Dis
; 69(3): 542-545, 2019 07 18.
Artigo
Inglês
| MEDLINE | ID: mdl-30590481
11.
96â¯weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.
J Hepatol
; 68(4): 672-681, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29756595
12.
Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection.
Clin Gastroenterol Hepatol
; 2018 Jun 20.
Artigo
Inglês
| MEDLINE | ID: mdl-29933096
13.
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B.
Aliment Pharmacol Ther
; 57(5): 509-523, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36427857
14.
Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells.
JHEP Rep
; 5(4): 100664, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36908748
15.
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study.
Korean J Intern Med
; 38(4): 504-513, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37424500
16.
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection.
JHEP Rep
; 4(1): 100388, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34950863
17.
Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B.
JHEP Rep
; 4(4): 100449, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35295767
18.
Prevalence of resistance-associated substitutions and phylogenetic analysis of hepatitis C virus infection in Russia.
Int J Infect Dis
; 113: 36-42, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34560266
19.
Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study.
Lancet Microbe
; 1(5): e200-e208, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32939459
20.
Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection.
J Clin Invest
; 130(6): 3205-3220, 2020 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32163375